- Home
- GSL vs SPRY Comparison
GSL vs SPRY Comparison
Compare GSL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSL | SPRY |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | Greece | United States |
| Employees | 11 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GSL | SPRY |
|---|---|---|
| Price | $37.40 | $8.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $43.50 | $40.00 |
| AVG Volume (30 Days) | 389.8K | ★ 952.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,278,000.00 |
| Revenue This Year | N/A | $109.11 |
| Revenue Next Year | N/A | $91.00 |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.73 | $6.66 |
| 52 Week High | $41.40 | $18.63 |
Technical Indicators
Market Signals| Indicator | GSL | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 31.56 |
| Support Level | $36.67 | $8.05 |
| Resistance Level | $38.52 | $10.44 |
| Average True Range (ATR) | 1.26 | 0.46 |
| MACD | -0.34 | -0.04 |
| Stochastic Oscillator | 16.49 | 7.41 |
Price Performance
Historical ComparisonAbout GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.